Xerox Corporation (XRX) - FREE Research Report

Liu Don H who is Sr Vice Pres, Gen Coun & Sec'y at Xerox Corporation sold 20,000 shares at $11.06 on Nov. 19, 2013. Following this transaction, the Sr Vice Pres, Gen Coun & Sec'y owned 153,799 shares meaning that the stake was reduced by 11.51% with the 20,000 share transaction.

The shares most recently traded at $11.00, down $0.06, or 0.51% since the insider transaction. Historical insider transactions for Xerox Corporation go as follows:

  • 12-Week # shares sold: 17,243
  • 24-Week # shares sold: 287,200

The average volume for Xerox Corporation has been 12.2 million shares per day over the past 30 days. Xerox Corporation has a market cap of $13.7 billion and is part of the technology sector and computer software & services industry. Shares are up 62.61% year to date as of the close of trading on Tuesday.

Xerox Corporation provides business process and document management services worldwide. The stock currently has a dividend yield of 2.07%. The company has a P/E ratio of 11.8. Currently there are 4 analysts that rate Xerox Corporation a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on XRX - FREE

TheStreet Quant Ratings rates Xerox Corporation as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, good cash flow from operations, notable return on equity, increase in net income and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Xerox Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Facebook and Snap Have One Issue That Will Have to Be Solved: Peter Bonfield

10 Biggest Takeaways from Apple's iPhone X Event

Google Pixel 2 Debuting October 4, FYI Apple

The iPhone X Highlights This Overlooked Strength of Apple's

Arconic, Idexx Laboratories, AbbVie: 'Mad Money' Lightning Round